Bliss GVS Pharma Allots 267,250 ESOP Shares

Bliss GVS Pharma Limited has made a regulatory disclosure regarding the allotment of shares under its Employee Stock Option Plan.

The ESOP Allotment Committee of the Company approved the allotment of 2,67,250 equity shares of face value Re. 1/- each to an eligible employee who exercised stock options under the Bliss GVS Pharma Limited–Employee Stock Option Plan 2019 ('Bliss GVS ESOP-2019'). The approval was granted at a meeting held on June 11, 2026.

Capital Structure Impact

Consequent to this allotment, the company's issued, subscribed and paid-up share capital has increased as follows:

• From: 10,57,88,973 equity shares of Re. 1/- each, aggregating ₹10,57,88,973
• To: 10,60,56,222 equity shares of Re. 1/- each, aggregating ₹10,60,56,222

Share Details

• Date of issue: June 11, 2026
• Number of shares issued: 2,67,250
• Par value: Re. 1/- per share
• Exercise price: ₹43/- per share
• Premium per share: ₹42/- per share
• Distinctive numbers: 10,57,88,973 to 10,60,56,222 (both inclusive)
• Total issued shares after this issue: 10,60,56,222

Lock-in Provisions

The allotted shares are subject to a lock-in period of 6 (six) months from the date of allotment, expiring on December 11, 2026. The shares are identical in all respects to existing shares and will rank pari passu with the existing equity shares of the Company.